DIASORIN Financial Statements From 2010 to 2026

34D Stock   72.62  0.22  0.30%   
Analyzing historical trends in various income statement and balance sheet accounts from DIASORIN (34DSG)'s financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting DIASORIN (34DSG)'s valuation are summarized below:
DIASORIN does not at this time have any fundamental measures for analysis.
Check DIASORIN (34DSG) financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DIASORIN (34DSG)'s main balance sheet or income statement drivers, such as , as well as many indicators such as . DIASORIN financial statements analysis is a perfect complement when working with DIASORIN (34DSG) Valuation or Volatility modules.
  
This module can also supplement various DIASORIN (34DSG) Technical models . Check out the analysis of DIASORIN (34DSG) Correlation against competitors.

DIASORIN Company EBITDA Analysis

DIASORIN (34DSG)'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current DIASORIN (34DSG) EBITDA

    
  517.3 M  
Most of DIASORIN (34DSG)'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DIASORIN is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition
According to the company disclosure, DIASORIN reported earnings before interest,tax, depreciation and amortization of 517.3 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.

DIASORIN (34DSG) Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining DIASORIN (34DSG)'s current stock value. Our valuation model uses many indicators to compare DIASORIN (34DSG) value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DIASORIN (34DSG) competition to find correlations between indicators driving DIASORIN (34DSG)'s intrinsic value. More Info.
DIASORIN is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for DIASORIN is about  1,842,857,885 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DIASORIN (34DSG)'s earnings, one of the primary drivers of an investment's value.

About DIASORIN (34DSG) Financial Statements

DIASORIN (34DSG) shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although DIASORIN (34DSG) investors may analyze each financial statement separately, they are all interrelated. The changes in DIASORIN (34DSG)'s assets and liabilities, for example, are also reflected in the revenues and expenses on on DIASORIN (34DSG)'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for DIASORIN Stock Analysis

When running DIASORIN (34DSG)'s price analysis, check to measure DIASORIN (34DSG)'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIASORIN (34DSG) is operating at the current time. Most of DIASORIN (34DSG)'s value examination focuses on studying past and present price action to predict the probability of DIASORIN (34DSG)'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIASORIN (34DSG)'s price. Additionally, you may evaluate how the addition of DIASORIN (34DSG) to your portfolios can decrease your overall portfolio volatility.